Lumexa Imaging Holdings, Inc.(LMRI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
LMRI Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Lumexa Imaging Holdings, Inc. (LMRI), a Healthcare sector company. LMRI is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2026), Lumexa Imaging Holdings, Inc. reports quarterly revenue of $252.5M, net income of $1.7M, an operating margin of 7.7%. Top institutional holders of LMRI by reported 13-F value include ALLIANCEBERNSTEIN L.P., MASSACHUSETTS FINANCIAL SERVICES CO /MA/, JANUS HENDERSON GROUP PLC, based on the most recent SEC filings. LMRI trades on the Nasdaq exchange and files with the SEC under CIK 2071288. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LMRI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Lumexa Imaging Holdings, Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$252.5M
Net Income
Q1 2026
$1.7M
Free Cash Flow
Q1 2026
$-2.4M
Operating Margin
Q1 2026
7.7%
ROIC
Q1 2026
1.4%
D/E Ratio
Q1 2026
1.41
AI Insight: LMRI Ratio Trends
Lumexa is severely unprofitable with razor-thin margins and deteriorating returns across all metrics.
• Net profit margin of 0.7% in Q1 2026 reflects near-breakeven operations despite 7.7% operating margin.
• ROE, ROA, and ROIC all remain critically low at 1.1%, 0.4%, and 5.4% respectively in Q1 2026.
• Leverage elevated at 1.41x D/E ratio, limiting financial flexibility in unprofitable state.
⚠ Massive gap between 7.7% operating margin and 0.7% net margin suggests material non-operating costs or tax burden.
⚠ Single-quarter data point limits trend visibility; monitor next 2–3 quarters for margin trajectory and profitability inflection.
Get alerted when LMRI's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Lumexa Imaging Holdings, Inc. including:
Top Institutional Holders of LMRI
ALLIANCEBERNSTEIN L.P.
$55.1M2,980,462 shMASSACHUSETTS FINANCIAL SERVICES CO /MA/
$20.1M2,334,580 shJANUS HENDERSON GROUP PLC
$18.1M2,100,356 shBROWN ADVISORY INC
$14.7M1,705,077 shArrowMark Colorado Holdings LLC
$14.2M1,653,258 shBlackRock, Inc.
$13.1M1,525,683 shInvesco Ltd.
$12.4M1,440,542 shHEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
$11.2M1,300,000 shVANGUARD CAPITAL MANAGEMENT LLC
$9.1M1,058,486 shEMERALD ADVISERS, LLC
$7.9M923,726 sh
| Fund | Value | Shares |
|---|---|---|
| ALLIANCEBERNSTEIN L.P. | $55.1M | 2,980,462 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $20.1M | 2,334,580 |
| JANUS HENDERSON GROUP PLC | $18.1M | 2,100,356 |
| BROWN ADVISORY INC | $14.7M | 1,705,077 |
| ArrowMark Colorado Holdings LLC | $14.2M | 1,653,258 |
| BlackRock, Inc. | $13.1M | 1,525,683 |
| Invesco Ltd. | $12.4M | 1,440,542 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $11.2M | 1,300,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.1M | 1,058,486 |
| EMERALD ADVISERS, LLC | $7.9M | 923,726 |
More Healthcare Companies
View all Healthcare →Put LMRI on your watchlist
Track score changes the day Lumexa Imaging Holdings, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is LMRI a good stock to buy?
13F Pro's AI-powered analysis of Lumexa Imaging Holdings, Inc. (LMRI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for LMRI are available on the LMRI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own LMRI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling LMRI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Lumexa Imaging Holdings, Inc.'s investment landscape.